Learn More
Medchemexpress LLC Larotinib mesylate hydrate | 2097129-93-4 | C26H36ClFN4O11S2 | 50 MG

Supplier: Medchemexpress LLC HY153110A50MG
Larotinib mesylate hydrate is a potent, broad-spectrum, and orally active tyrosine kinase inhibitor (TKI) with EGFR as its primary target, demonstrating an IC50 of 0.6 nM. This compound is intended for research use only.
- Potent broad-spectrum and orally active tyrosine kinase inhibitor
- Primary target is EGFR with an IC50 of 0.6 nM
- Purity of 98.66%
- Appears as a white to off-white solid
- Molecular weight of 699.17
- Soluble in DMSO at 25 mg/mL (35.76 mM)
- Stock solution can be stored at -80°C for 6 months or -20°C for 1 month (sealed, away from moisture)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.